Editor Note - Journal of Medical Oncology and Therapeutics (2020) Volume 5, Issue 1

Journal of Medical Oncology and Therapeutics: Editorial Note

Ken H. Young

Associate Professor, Department of Hematopathology, The University of Texas MD Anderson Cancer Center, USA.

*Corresponding Author:

Ken H. Young
Associate Professor, Department of Hematopathology
The University of Texas MD Anderson Cancer Center, USA.
E-mail: KHYoung@mdanderson.org

Accepted date: April 26, 2020

Abstract

Autoimmunity is present both in some rheumatic diseases and in cancer with a bidirectional interaction

Journal of Medical Oncology and Therapeutics belongs to allied academies with 25+ million website visitors and 30537+ journal visitors. Journal of Medical Oncology and Therapeutics started in the year of 2016 and has successfully completed its four volumes and now going to start its fifth volume by 2020. During this period, Journal of Medical Oncology and Therapeutics achieved good readership and honor from the scientific societies.

The main objective for Journal of Medical Oncology and Therapeutics is one of the reputed open access, Peer reviewed journal that deals and describes the developmental activities conducted in the vast field of oncological research. The journal aims to publish the current advancements and developments related to Breast Cancer, Cell Line, Prostate Cancer, Tumor Cells, Genetics, Radiation Therapy, Lung Cancer, Prognostic Factor, Colorectal Cancer, Non-Small Cell Lung Cancer, Ovarian Cancer, Cell Cycle, Gene Expression, Cell Proliferation, Breast Carcinoma, Squamous Cell Carcinoma, Transcription Factor, Monoclonal Antibody and Hepatocellular Carcinoma discipliness

Major highlights in 2019 were all the issues of volume 4 were published online well within the time and the print issues were also brought out and dispatched within 30 days of publishing the issue online. This journal is having a high-quality perfection in publishing the articles within the time. based on research articles, A mini review on ‘Basaloid and lobulated: Sebaceous adenoma’ was written by Dr. Roland Cheofor Ngu, MD, A.B. Diagnostics, New Delhi, India and a short communication on ‘The mysteries of S6K2 may shed light to breast cancer therapy path’ by Dr. Nurettin ?lter Sever from Department of Molecular Biology and Genetics, Pamukkale University, Denizli Turkey. Based on 2019 conference proceedings highlights regarding International Conference on cancer and cancer therapy, oncology nursing and cancer care, cancer stem cells and oncology research, oncology & cancer therapy etc.

The Editorial board members providing there best in handling the articles with an Editor-in-Chief, twenty-nine Associate Editors and fifteen Section Editors. The Journal is using Editor Manager System for easy online tracking and managing of the manuscript processing. Each article undergoes a peer review process under the aegis of an assigned Editor. To be acceptable for publication, an article should be positively considered by two individual reviewers followed by the Editor’s consent.

The journal has so far Published Voluminous Issues on oncology and hematology and other issues, challenges and therapeutic solutions to various fields. Under the able stewardship of Ken H. Young, from The University of Texas MD Anderson Cancer Center, USA as an Editor-in-Chief, world renowned researchers, scientists, and academicians including an Executive Editor Gayatri Sharma, from Medical College of Wisconsin, Wisconsin, Mostafa Norizadeh Tazehkand, from Bulent Ecevit University, Zonguldak, Turkey, OBEAGU EMMANUEL IFEANYI, from Michael Okpara University of Agriculture Umudike, Abia State, Nigeria, Sambhaji Govind Chintale, from Muhs Nashik University Maharashtra, India, Saju Joseph, from Texas Tech University Health Sciences Center, USA, Daolin Tang, from University of Pittsburgh, USA, Ciro Manzo, from Mariano Lauro hospital, Sant'Agnello, Italy, EL-Habib Dakir, from Bradford University, UK, Hiu Yee Kwan, from HongKong Baptist University, HongKong, Antonio Simone Lagana, from University of Messina, Italy, Sayed M. Hassan, from University of Georgia, USA, Christopher Michael Gallagher, from MedStar Washington Hospital Center, USA, Alfio Ferlito from University of Udine, Italy, Kumar Jayant from Imperial College London, UK, Claudio Luchini from University of Verona, Italy, Danish Mahmood from Qassim University, Saudi Arabia, Biplab Giri from University of Gour Banga, India, Daolin Tang from Guangzhou Medical University, China, Hongming Miao from Third Military Medical University, China, Yuan-Yuan Zhang from Sichuan University, China and Clevia dos Santos Passos from Medical School of University of Sao Paulo, Brazil are acting as Editorial Board Members to add significant value to the research in the field of Public Health and Safety.

A statistical representation of global users for Journal of Medical Oncology and Therapeutics through a source called Google Analytics. Google Analytics is a data that browser, viewers, and users are constantly visiting the web page of the journal from various quarters of the world 24×7. Approximately 6,749 visitors have accessed the journal pages for reading and deriving information for their use. Majority of countries visiting journal website are from India 90%, United States 70%, and other countries are also visiting for the best outcomes. Social media and digital marketing is also helpful in advertising for manuscript submission through Tweeter, LinkedIn, what’s app, G-suit and outlook mailing.

I would like to acknowledge my heartfelt gratitude to editors, authors, reviewers and other journal holders for their dedication in future growth for Journal of Medical Oncology and Therapeutics and it provides optimum platform where researchers from all over world can submit their work to it. Journal of Medical Oncology and Therapeutics is a famed international journal having an impeccable Reviewer and Editorial Board.